These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6681739)

  • 41. Prednisolone Effects on Urine Cross-Linked N-Telopeptides of Type I Collagen (Ntx) Diurnal Rhythms in Children.
    Wolthers OD; Heuck C
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):158-161. PubMed ID: 29366431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circadian variation of cyclosporine A in renal transplanted patients.
    Reyna Rodríguez C; Jung Cook H; González López EH; Nava A
    Rev Alerg Mex; 2004; 51(1):9-12. PubMed ID: 15119750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prednisolone elimination in human saliva.
    Al-Habet SM; Rogers HJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):485-7. PubMed ID: 4055160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circadian stage-dependent changes in diazepam kinetics.
    Nakano S; Watanabe H; Nagai K; Ogawa N
    Clin Pharmacol Ther; 1984 Aug; 36(2):271-7. PubMed ID: 6744785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism.
    Frey FJ; Horber FF; Frey BM
    Clin Pharmacol Ther; 1988 Nov; 44(5):510-21. PubMed ID: 2972434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of prednisolone kinetics in patients receiving daily or alternate-day prednisone for asthma.
    Greenberger PA; Chow MJ; Atkinson AJ; Ambre JJ; Patterson R
    Clin Pharmacol Ther; 1986 Feb; 39(2):163-8. PubMed ID: 3943272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study.
    Galbo H; Kall L
    Arthritis Res Ther; 2016 Jul; 18(1):174. PubMed ID: 27455959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of plasma prednisolone in man.
    Wilson CG; Ssendagire R; May CS; Paterson JW
    Br J Clin Pharmacol; 1975 Aug; 2(4):321-5. PubMed ID: 1233991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of concurrent administration of antacids on prednisolone absorption.
    Lee DA; Taylor GM; Walker JG; James VH
    Br J Clin Pharmacol; 1979 Jul; 8(1):92-4. PubMed ID: 552304
    [No Abstract]   [Full Text] [Related]  

  • 51. Distribution of [3H]prednisolone entrapped in lipid layer of liposome after intramuscular administration in rats.
    Shinozawa S; Araki Y; Oda T
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):223-32. PubMed ID: 461983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability of prednisolone in asthmatic patients with a poor response to steroid treatment.
    Mortimer O; Grettve L; Lindström B; Lönnerholm G; Zetterström O
    Eur J Respir Dis; 1987 Nov; 71(5):372-9. PubMed ID: 3443161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM; Seeberger M; Frey FJ
    Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
    Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
    Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prednisolone levels in plasma and leukemia cells during therapy of chronic lymphocytic leukemia.
    Panesar NS; Bird CC; Roberts BE; Child JA
    J Pharm Sci; 1984 Jan; 73(1):66-8. PubMed ID: 6694086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypothalamic-pituitary-adrenal axis recovery following prolonged prednisolone therapy in infants.
    Mendoza-Cruz AC; Wargon O; Adams S; Tran H; Verge CF
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1936-40. PubMed ID: 24081733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Gut; 1980 Jan; 21(1):52-6. PubMed ID: 7364321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salivary kinetics of prednisolone in man.
    Lowe JR; Dixon JS
    J Pharm Pharmacol; 1983 Jun; 35(6):390-1. PubMed ID: 6135782
    [No Abstract]   [Full Text] [Related]  

  • 60. Chronopharmacology.
    Marks V; English J; Aherne W; Arendt J
    Clin Biochem; 1985 Jun; 18(3):154-7. PubMed ID: 3888443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.